Beta Blocker Use in Cardiac Surgery and Association With Postoperative Course

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1789 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-30

Study Completion Date

2023-12-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to describe in a cohort of cardiac surgery patients the use of beta-blockers before surgery and their maintenance or withdraw according to international recommendations in order to compare patients who receive a beta-blocker with maintenance during the surgical period (international recommendation) to those for whom prescription and maintenance are not respected. Patients are treated according to standard practice and this protocol does not change patient management. No additional information or data is required by the study other than the data usually collected in the patient record (drug treatment, medical history, operating data, postoperative data, complications, length of stay).

The objectives of this research are :

* To evaluate the proportion of patients receiving beta-blocker treatment prior to cardiac surgery.
* To evaluate the proportion of patients receiving beta-blocker treatment before cardiac surgery and complying with international recommendations for its maintenance/stop in perioperative cardiac surgery.
* To evaluate the incidence of complications and length of hospital stay in patients receiving beta-blockers based on compliance or non-compliance with recommendations.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Optimizing Expectations in Cardiac Surgery Patients

NCT01407055

Coronary Artery Bypass Graft Surgery (CABG) Patients' Expectations Coronary Heart Disease

COMPLETED PHASE2

Anesthesia Standard Operating Procedure During On-pump Coronary Artery Bypass Grafting

NCT05514652

Coronary Artery Disease Low Cardiac Output Syndrome Atrial Fibrillation +1 more

UNKNOWN NA

Long-Term Cognitive Decline After Coronary Artery Bypass Grafting: is Off-Pump Surgery Beneficial?

NCT00189215

Coronary Artery Disease Cardiopulmonary Bypass Cognition Disorders

COMPLETED PHASE4

Maintaining Mechanical Ventilation During Cardiopulmonary Bypass for Cardiac Surgery

NCT03372174

Cardiopulmonary Bypass

COMPLETED NA

Cardiopulmonary Bypass (CPB) Pumps and Blood Activation

NCT00187967

Cardiopulmonary Bypass Coronary Artery Disease

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Surgery With Cardiopulmonary Bypass

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No beta-blocker

Patient do no treat with beta-blocker before the surgery

collection of the allocated treatment

Intervention Type OTHER

collection of the allocated treatment

collection of medical complications

Intervention Type OTHER

collection of medical complications

Beta blocker

Patient treat with beta-blocker in accordance to international guidelines

collection of the allocated treatment

Intervention Type OTHER

collection of the allocated treatment

collection of medical complications

Intervention Type OTHER

collection of medical complications

Beta blocker2

Patient treat with beta-blocker without respect of international guidelines

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

collection of the allocated treatment

Intervention Type OTHER

collection of medical complications

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Major patient ≥ 18 years
* Patient operated cardiac surgery with cardiopulmonary bypass
* Patients who have given oral consent to participate after full information